Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motixafortide and G-CSF for Stem Cell Mobilization in Multiple Myeloma
NCT06514508Phase 3Recruiting
- Sponsor
- Guangzhou Gloria Biosciences Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
A Phase 3 trial of motixafortide in multiple myeloma (MM), sponsored by Guangzhou Gloria Biosciences Co., Ltd.. Started Dec 2025; status: recruiting.
02
Drugs
motixafortide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06514508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514508.